Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000248257 | SCV000310083 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000675811 | SCV000979456 | benign | not provided | 2018-06-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001554040 | SCV001775185 | benign | Farber lipogranulomatosis | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554041 | SCV001775186 | benign | Spinal muscular atrophy-progressive myoclonic epilepsy syndrome | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000675811 | SCV005265985 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000675811 | SCV000801533 | benign | not provided | 2015-10-22 | no assertion criteria provided | clinical testing |